Amalgamated Bank’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-998
Closed -$6K 3049
2023
Q1
$6K Sell
998
-25
-2% -$201 ﹤0.01% 2876
2022
Q4
$13K Hold
1,023
﹤0.01% 2835
2022
Q3
$24K Buy
1,023
+602
+143% +$18.3K ﹤0.01% 2756
2022
Q2
$14K Buy
+421
New +$34.2K ﹤0.01% 2928

Other funds holding CELU

Amalgamated Bank's CELU Position: Q2 2023 in Review

Amalgamated Bank sold out of Celularity (CELU) in Q2 2023, closing a stake of 998 shares — an estimated $6K sold.

Amalgamated Bank first reported a position in CELU in Q2 2022 and held it in 4 quarters. The position peaked at $24K in Q3 2022. 56 funds tracked by Wall St. Rank hold CELU as of Q2 2023.

  • Amalgamated Bank reported no remaining Celularity position as of Q2 2023 after selling out during the quarter.
  • Amalgamated Bank sold 998 Celularity shares in Q2 2023, an estimated $6K.
  • Amalgamated Bank first reported a position in Celularity in Q2 2022 and held it in 4 quarters.
  • Amalgamated Bank's Celularity position peaked at $24K in Q3 2022.
  • 56 funds tracked by Wall St. Rank held Celularity as of Q2 2023.

Based on Amalgamated Bank's 13F filing for Q2 2023, filed 11 Aug 2023.